 |
|
What people are saying - Write a reviewWe haven't found any reviews in the usual places. Related books
Contents
Other editions - View allCommon terms and phrasesactive control Active drug addition adverse events agent analysis assessment baseline bias blinded cancer censored Chow clinical data clinical endpoints clinical trial protocol clinical trials combination compared concurrent control conducted confidence interval considered COSTART covariates criteria crossover design database disease distribution dose level dose-response dose-response relationship double-blind efficacy and safety equivalence error estimated example function given group sequential guideline indicated interaction interim analyses investigation laboratory level of significance MedDRA ment monitoring multicenter trial myocardial infarction noninferiority null hypothesis number of patients number of subjects observed obtained p-value parameters pharmaceutical phase procedures protocol randomization codes regulatory reject the null result sample sample size Section selection sponsor standard statistical inference streptokinase Table Tacrine target patient population test drug product test statistic therapy tion titration treatment effect treatment groups type I error usually vaccine valid variability variance Popular passagesPage 22 - As used in this subsection and subsection (e), the term "substantial evidence" means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended,... Page 12 - Pharmacopeia, or any supplement to them, (2) intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man... Page 22 - ... substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof. . . . [T]he term "substantial evidence... Page 23 - If the protocol does not contain a description of the proposed methods of analysis, the study report should describe how the methods used were selected. (2) The study uses a design that permits a valid comparison with a control to provide a quantitative assessment of drug effect. The protocol for the study and report of results should describe the study design precisely; for example, duration of treatment periods, whether treatments are parallel, sequential, or crossover, and whether the sample size... Page 12 - biological product" as "any virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product or analogous product ' ' * applicable to the prevention, treatment, or cure of diseases or injuries of man... Page 14 - Phase 2 includes the controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. Phase... References to this bookFrom other books
From Google ScholarUneasy Alliance-Clinical Investigators and the Pharmaceutical IndustryThomas Bodenheimer - 2000 - New England Journal of Medicine Do medical devices have enhanced placebo effects?Ted J Kaptchuk, Peter Goldman, David A Stone, William B Stason - 2000 - Journal of Clinical Epidemiology Gabapentin versus Lamotrigine Monotherapy: A Double-blind ...Martin J Brodie, David W Chadwick, Henning Anhut, Andreas Otte, Silke-Lo Messmer, Stephen Maton ... - 2002 - Epilepsia Pharmacological treatment of social anxiety disorder: A meta-analysisCarlos Blanco, Franklin R Schneier, Andrew Schmidt, Carmen-Rosa Blanco-Jerez, Randall D Marshall ... - 2003 - Depression and Anxiety References from web pagesDesign and Analysis of Clinical Trials: Concepts and Methodologies ... Design and Analysis of Clinical Trials (2nd ed.). | Science ... Jossey-Bass::Design and Analysis of Clinical Trials: Concepts and ... 3021 Shein- Chung Chow and Jen-Pei Liu, Wiley, Chichester, 1998 ... Wiley-VCH - Chow, Shein-Chung / Liu, Jen-Pei - Design and Analysis ... faculty Design and Analysis of Clinical Trials: Concepts and Methodologies ... Biostatistics & Bioinformatics :: Duke Faculty Blackwell Synergy - Biometrics, Volume 60 Issue 3 Page 843-844 ... CORE Randomized Clinical Trials Outcome Resources Page Bibliographic information
|